Friday, September 4, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 10, 2026

Moxie Raises $25M Series C to Bring Clinical-Grade Operating Infrastructure to Independent Aesthetic Practices

View original at globenewswire.com
Moxie Raises $25M Series C to Bring Clinical-Grade Operating Infrastructure to Independent Aesthetic Practices BROOKLYN, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Moxie, the clinical-grade operating system for aesthetic medicine, today announced a $25 million Series C funding round led by Viewpoint Ventures, with partic…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Moxie helps aesthetic entrepreneurs save 25+ hours each week

    60% confidence
  • Moxie let me stop being a firefighter and start being a CEO. The financial clarity alone changed how I make decisions. Moxie has helped me gain control over my business so my business doesn't have control over me.

    60% confidence
  • The aesthetic practices that thrive long-term aren't the loudest or the busiest. They're the most disciplined. We built Moxie to give independent practice owners the same caliber of operating infrastructure that was previously only available to those backed by institutional capital.

    60% confidence
  • Aesthetic medicine has grown faster than its infrastructure. We have world-class clinicians running practices on spreadsheets and workarounds — and that's a risk to patients, to margins, and to the long-term credibility of the specialty. Clinically-led growth isn't a marketing phrase. It's the operating discipline that separates practices that scale from practices that collapse under their own weight.

    60% confidence
  • Moxie-supported practices save up to 55% on injectables, devices, and supplies with top-tier pharmaceutical, skincare, and manufacturing companies

    60% confidence
  • Moxie-supported practices grow 60% faster than the industry average

    60% confidence
  • Moxie-supported practices achieve 10% higher margins than industry average

    60% confidence
  • Moxie-supported practices save more than $5,000 per month on products and supplies

    60% confidence
  • Up to 30% of new medspas fail within 18 to 24 months

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com